Neuropace
NPCE
NPCE
51 hedge funds and large institutions have $109M invested in Neuropace in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 21
38% less capital invested
Capital invested by funds: $176M → $109M (-$67.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
51
Holding in Top 10
1
Calls
$214K
Puts
$2K
Top Buyers
| 1 | +$4.94M | |
| 2 | +$4.51M | |
| 3 | +$3.78M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.62M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.32M |
Top Sellers
| 1 | -$4.52M | |
| 2 | -$2.69M | |
| 3 | -$1.22M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$998K |
| 5 |
Jane Street
New York
|
-$951K |